The case of comorbidity of sinus node dysfunction and new coronavirus infection with Sjogren’s disease and Thompson’s myotonia

Abstract

Coronavirus infection, according to modern data, poses a threat not only to the respiratory system, in more than 15% of patients it can lead to cardiovascular complications, including in young and middle-aged people. COVID-19 is probably the trigger of a detailed clinical picture of chronic diseases occurring in a latent form. The article considers the case of sinus node dysfunction and polyneuropathy in a young patient after coronavirus infection against the background of concomitant diseases such as Sjogren’s disease and Thompson’s myotonia. To observe the dynamics of the three diseases, the timely organization of a multidisciplinary approach is important. It is necessary to consider all three diseases in the paradigm of the main and concomitant in order to timely and adequate therapy. Further study of the clinical features, therapeutic approaches and complications in patients with COVID-19 is required.

Keywords

coronavirus infection / cardiovascular complications / sinus node dysfunction / bradyarrhythmia / polyneuropathy / Thompson’s myotonia / Sjogren’s disease

References

[1] Revishvili AS, Artyukhina EA, Glezer MG, et al. 2020 Clinical practice guidelines for Bradyarrhythmias and conduction disorders. Russian Journal of Cardiology. 2021;26(4):203–245. (In Russ.). DOI: 10.15829/1560-4071-2021-4448

[2] Ревишвили А.Ш., Артюхина Е.А., Глезер М.Г. и др. Брадиаритмии и нарушения проводимости. Клинические рекомендации 2020 // Российский кардиологический журнал. 2021. Т. 26, № 4. С.203–245. DOI: 10.15829/1560-4071-2021-4448

[3] Miokardity. Klinicheskie rekomendatsii 2020 [Internet]. Available from: Clinic_rekom_Miokardit.pdf (scardio.ru). Accessed: 15.09.2021. (In Russ.)

[4] Миокардиты. Клинические рекомендации 2020 [Электронный ресурс]. Режим доступа: Clinic_rekom_Miokardit.pdf (scardio.ru). Дата обращения: 15.09.2021.

[5] Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin Med J (Engl). 2020;133(9):1025–1031. DOI: 10.1097/ CM9.0000000000000744

[6] Liu K., Fang Y.Y., Deng Y. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province // Chin. Med. J. (Engl). 2020. Vol. 133, No. 9. P. 1025–1031. DOI: 10.1097/ CM9.0000000000000744

[7] Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. DOI: 10.1001/jamacardio.2020.1017

[8] Guo T., Fan Y., Chen M. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) // JAMA Cardiol. 2020. Vol. 5, No. 7. P. 811–818. DOI: 10.1001/jamacardio.2020.1017

[9] Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. DOI: 10.1001/jama.2020.6775

[10] Richardson S., Hirsch J.S., Narasimhan M. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area // JAMA. 2020. Vol. 323, No. 20. P. 2052–2059. DOI: 10.1001/jama.2020.6775

[11] Peigh G, Leya MV, Baman JR, et al. Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series. Eur Heart J Case Rep. 2020;4(FI1):1–6. DOI: 10.1093/ehjcr/ytaa132

[12] Peigh G., Leya M.V., Baman J.R. et al. Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series // Eur. Heart J. Case Rep. 2020. Vol. 4, No. FI1. P. 1–6. DOI: 10.1093/ehjcr/ytaa132

[13] Cimino G, Pascariello G, Bernardi N, et al. Sinus node dysfunction in a young patient with COVID-19. JACC Case Rep. 2020;2(9):1240–1244. DOI: 10.1016/j.jaccas.2020.05.067

[14] Cimino G., Pascariello G., Bernardi N. et al. Sinus node dysfunction in a young patient with COVID-19 // JACC Case Rep. 2020. Vol. 2, No. 9. P. 1240–1244. DOI: 10.1016/j.jaccas.2020.05.067

[15] Kardiologiya: natsional’noe rukovodstvo. Ed. by E.V. Shlyakhto. 2nd ed. Moscow; 2015. (In Russ.)

[16] Кардиология: национальное руководство / под ред. Е.В. Шляхто. 2-е изд., перераб. и доп. М., 2015.

[17] Nevrologiya. Natsional’noe rukovodstvo. Vol. 1. Ed. by E.I. Gusev, A.N. Konovalov, V.I. Skvortsova, A.B. Gekht. Moscow; 2018. (In Russ.)

[18] Неврология. Национальное руководство. Том 1 / под ред. Е.И. Гусева, А.Н. Коновалова, В.И. Скворцовой, А.Б. Гехт. М., 2018.

[19] Federal’nye klinicheskie rekomendatsii po diagnostike i lecheniyu bolezni Shegrena [Internet]. Available from: http://www.ma.cfuv.ru/docs/249615/Болезнь%20Шегрена.pdf. Accessed: 15.09.2021. (In Russ.)

[20] Федеральные клинические рекомендации по диагностике и лечению болезни Шегрена [Электронный ресурс]. Режим доступа: http://www.ma.cfuv.ru/docs/249615/Болезнь%20Шегрена.pdf. Дата обращения: 15.09.2021.

[21] Revmatologiya: natsional’noe rukovodstvo. Ed. by E.L. Nasonov, V.A. Nasonova. Moscow; 2010. (In Russ.)

[22] Ревматология: национальное руководство / под ред. Е.Л. Насонова, В.А. Насоновой. М., 2010.

[23] Sakovets TG. Clinical features of lesions of the nervous system in patients with Sjogren disease. Practical Medicine. 2017;(8):122–125. (In Russ.)

[24] Саковец Т.Г. Клинические особенности поражения нервной системы у пациентов с болезнью Шегрена // Практическая медицина. 2017. № 8. С. 122–125.

[25] Vertkin AL, Rumyantsev MA, Skotnikov AS, et al. Comorbidity: from the beginnings to the modern concept of development. How to evaluate and predict. Kardiolog. 2011;(9):3–13. (In Russ.)

[26] Вёрткин А.Л., Румянцев М.А., Скотников А.С. и др. Коморбидность: от истоков развития до современного понятия. Как оценить и прогнозировать // Кардиолог. 2011. № 9. С. 3–13.

[27] Lila AM, Gordeev AV, Olyunin YuA, Galushko EA. Multimorbidity in rheumatology. From comprehensive assessment of disease to evaluation of a set of diseases. Modern Rheumatology Journal. 2019;13(3):4–9. DOI: 10.14412/1996-7012-2019-3-4-9

[28] Лила А.М., Гордеев А.В., Олюнин Ю.А., Галушко Е.А. Мультиморбидность в ревматологии. От комплексной оценки болезни — к оценке комплекса болезней // Современная ревматология. 2019. Т. 13, № 3. С.4–9. DOI: 10.14412/1996-7012-2019-3-4-9

RIGHTS & PERMISSIONS

Mohika Estepa M.O., Muzhikina N.V.